Moderation Best Practices for Pharma Social Networks Pre, Post, or No Moderation… Whatever. You Must Have a Plan!
As pharmaceutical companies attempt to interact with consumers and patients on social media networks they host, they are wary of overstepping undefined regulatory boundaries. One issue that requires clarification concerns accountability for user-generated content posted on these pharma owned and controlled social networks such as comments submitted to Facebook pages and YouTube channels.
While the FDA mulls over new guidelines that define those boundaries, pharma companies are launching new social media sites with increasing frequency. Although these sites may not be branded and may have terms of use specifying what is acceptable and unacceptable user-generated content, the question remains how to enforce those rules through moderation, especially with regard to handling of off-label information. Although this is a moot point at the moment – almost all such sites have comments turned off – it is important to have a moderation strategy designed to meet your specific goals when and if you build a truly interactive social network.
This article presents a summary of results from a recent survey of readers and other experts regarding pharma social media moderation best practices.
Topics include:
- What’s Your Social Media Implementation Plan?
- Unmoderated Discussions
- Does Pre-Screening Inhibit Discussion?
- Post-Moderation Best Practices
- Who Should Moderate?
Read this article now. It’s FREE…
PMN94-03
Issue: Vol. 9, No. 4: April 2010
Word Count: 3064
Also see these articles, blog posts, and podcasts relating to moderation of online discussions:
- Moderation of Pharma Social Media Discussions (podcast)
- How to Manage the Online Conversation
- What’s Your Social Media Implementation Plan? (pdf file)
- What Has Sanofi-Aventis Learned from Its Facebook Experience?
Find other articles in related Topic Areas:
